entity

Cytoplasm

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Cytoplasm: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
13Hypotheses
2Analyses
0Outgoing
5Incoming
0Experiments
2Debates

No AI portrait yet

Wiki Pages (10)

Knowledge base pages for this entity

Glial Cytoplasmic Inclusions in Neurodegeneration

mechanism · 2282 words

DYNC1LI1 — Dynein Cytoplasmic 1 Light Intermediate Chain 1

gene · 2059 words

DYNC2H1 — Dynein Cytoplasmic 2 Heavy Chain 1

gene · 1646 words

Cytoplasmic Dynein 1 Intermediate Chain 1 (DYNC1I1)

protein · 1561 words

Glial Cytoplasmic Inclusions in Multiple System Atrophy

mechanism · 1453 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (5)

SourceRelationTypeStr
NPM1transportsprotein0.90
Chmp2Bwtexpressed_inprotein0.90
CHMP2BΔ10expressed_invariant0.90
TDP-43accumulatesprotein0.90
DNAJB6bregulatesprotein0.70

Targeting Hypotheses (13)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
C9orf72 Hexanucleotide Repeat Dipeptide Repeat Proteins Inhi 0.738 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
TDP-43 condensation thermodynamics as a therapeutic target a 0.724 neuroscience How can subcellular compartmentalization
RNA-binding protein condensate maturation from reversible ph 0.626 neurodegeneration Causal Sequence of TDP-43 Nuclear Cleara
Cell-state stratification is required to resolve Causal Sequ 0.612 neurodegeneration Causal Sequence of TDP-43 Nuclear Cleara
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration Causal Sequence of TDP-43 Nuclear Cleara
C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD 0.597 neurodegeneration Test
RNA Metabolism and Nucleocytoplasmic Transport Defects 0.580 neurodegeneration Cross-disease neurodegeneration mechanis
Nucleocytoplasmic Transport Disruption 0.520 neurodegeneration What mechanisms underlie TDP-43's contri
SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 0.511 als What are the mechanisms by which microgl
Nuclear Pore and Nucleocytoplasmic Transport Machinery as Ga 0.500 neurodegeneration What determines the specificity of RNA-p
TDP-43 Phase Separation Destabilization Drives Cytoplasmic A 0.500 neurodegeneration Test
Nuclear Export Sequestration and Cytoplasmic Depletion 0.475 - How does the intron-retained RNA isoform
SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclea 0.361 als What are the mechanisms by which microgl

Mentioning Analyses (2)

Scientific analyses that reference this entity

Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43

neurodegeneration | 2026-04-12 | 0 hypotheses

What are the specific design principles for small molecules that can selectively

medicinal chemistry | 2026-04-10 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (4)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells. [PMID:41000837] Unknown bioRxiv 2025 0
Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopat [PMID:34412701] Unknown Acta Neuropathol Commun 2021 0
Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP- [PMID:30458231] Unknown Neurobiology of disease 2019 0
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synaps [PMID:28669544] Unknown Neuron 2017 0

Debates (2)

Multi-agent debates referencing this entity

The debate identified that TDP-43 undergoes both normal and pathological phase s

closed · Rounds: 4 · Score: 0.43 · 2026-04-21

The debate revealed that DNAJB6 evidence is limited to polyglutamine aggregation

closed · Rounds: 4 · Score: 0.79 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Cytoplasm in their description or question text

C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD

Score: 0.597 · neurodegeneration · 2026-05-06

C9orf72 intronic GGGGCC repeats produce dipeptide repeat proteins and RNA foci that sequester nuclear import factors (TN

RNA Metabolism and Nucleocytoplasmic Transport Defects

Score: 0.580 · neurodegeneration · 2026-04-28

Impaired RNA processing and disrupted nucleocytoplasmic transport represent a convergent molecular phenotype, but most c

Nucleocytoplasmic Transport Disruption

Score: 0.520 · neurodegeneration · 2026-04-21

## Mechanistic Overview Nucleocytoplasmic Transport Disruption starts from the claim that modulating NUP107 within the d

SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 Nuclear Retention L

Score: 0.511 · als · 2026-04-27

The hypothesis proposes that MMP-9 (matrix metalloproteinase-9), secreted via the senescence-associated secretory phenot

Nuclear Pore and Nucleocytoplasmic Transport Machinery as Gatekeepers

Score: 0.500 · neurodegeneration · 2026-04-21

## Mechanistic Overview Nuclear Pore and Nucleocytoplasmic Transport Machinery as Gatekeepers starts from the claim that

TDP-43 Phase Separation Destabilization Drives Cytoplasmic Aggregation

Score: 0.500 · neurodegeneration · 2026-05-03

Aberrant arginine methylation prevents TDP-43 liquid-liquid phase separation, promoting pathogenic aggregation. PRMT5-me

Nuclear Export Sequestration and Cytoplasmic Depletion

Score: 0.475 · unknown disease · 2026-04-26

Retained intronic sequences contain cryptic nuclear retention elements that recruit export inhibitory complexes (PHAX, A

SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transp

Score: 0.361 · als · 2026-04-26

This hypothesis proposes that MMP-9 secreted by senescent microglia in the SASP drives ALS pathology through disruption